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1. Introduction 
Pulmonary thromboembolism (PE) is a relatively common cardiovascular emergency and it 
is healthy important issue. Overall, VTE occurs for the first time in approximately 1 case per 
1000 each year. PE has been estimated to occur in 600,000 patients annually in the United 
States and is reported to cause or attribute to 50,000 to 200,000 deaths (Wood, 2002). PE is a 
difficult diagnosis that may be missed because of non-specific clinical presentation. Clinical 
scoring systems have been widely used to determine the risk of PE (Table 1). These scoring 
systems include age and cancer which can be risk factors causing PE. However specificity 
and sensitivity of these scoring systems range from 60-85% to 50-80% in a current 
metaanalysis(Lucassen, 2011). An increased prevalence of PE was found associated with 
higher sensitivity and lower specificity. Thus lower specificity of these scoring systems 
cause the unnecessary diagnostic workup.  Diagnosis of PE by pulmonary computerized 
tomography angiography has been increasing in the last 10 years. Actually, Pulmonary CTA 
confirmed PE in only a minority of patients and may be overused. A retrospective study 
demonstrated that pulmonary CTA was positive for PE in only 39 (14.9%) of 261 patients. 
(Haap, 2011) 
In addition, during the past 2 decades, prevention of venous thromboembolism (VTE) has 
become widely accepted as an effective and worthwhile strategy. North American and 
European guidelines have provided detailed recommendations for prophylaxis among 
virtually all groups of hospitalized patients, especially in those with heart failure, active 
cancer, or sepsis. 
However, despite advances in prophylaxis and newer diagnostic methods delays in the 
diagnosis of PE is stil common. Pulmonary embolism has been determined in 15% of the 
autopsy series, whereas the antemortem diagnosis of fatal PE has not changed appreciably 
over time, remaining fixed at approximately 30% [Wood,2002]. Most patients who die of PE 
do so within hours of the event (Dalen,2002). 30% of all hospital deaths are also caused by 
pulmonary embolism. Whereas, earlier diagnoses of DVT and PE will reduce the morbidity 
and mortality associated with venous thromboembolism. 
In several studies, 16% to 30.4% of the patients with acute PE were diagnosed one week or 
longer after the symptom onset, and the mean time to diagnosis was 4.8 to 8.4 days. It has  
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Table 1. Clinical probability rules for PE: revised Geneva score and Wells score. 
been reported that 31.6% to 50% of the patients presented within 24 hours of symptom onset 
[Bulbul 2009,Castro,2007, Elliott 2005,Timmons 2003]. In our study, 29.6% of the patients 
had presented within the first 24 hours and 72.3% within the first week, with an average of 
6.9 days between onset of symptoms and diagnosis. In the two previous studies, delays 
from first medical attention to diagnosis were determined to range from 0.9 to 2 days 
[Bulbul 2009, Elliott 2005]. In another study, PE was diagnosed in 12% of the patients more 
than 48 hours after admission to the ED [Kline,2007]. In our study, the mean time to 
diagnosis was found as 2.4 days. As a result, the majority of patients that die from PE do so 
within hours of the event. Therefore, early diagnosis is fundamental, since immediate 
treatment is highly life-saving. 
The most important factor in the delayed diagnosis of PE is lack of suspicion for the PE 
disease itself.  In addition to this, accompanying comorbidities and risk factors may affect 
the time to diagnosis. The presence of a risk factor in PE is important step in the diagnosis of 
PE and it should be questioned. Although PE can occur in patients without any identifiable 
risk factors, one or more of these factors are usually determined (secondary PE). Symptoms 
are often attributed to these diseases because of risk factors and associated comorbidities. 
Therefore it is inevitable to cause diagnostic delay. The proportion of patients with 
idiopathic or unprovoked PE was about 20% in the literature. Actually it seems to be a 
important factor to cause delays in diagnosis of pulmonary embolism.  
In this section, we will investigated the effect of risk factors on delay to diagnosis in acute 
PE and also the relationship between delays and outcome of the disease. 
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2. Definitions 
The time from the onset of symptoms to diagnosis was defined as “time to diagnosis” and 
delay from the first medical attention to diagnosis “presentation to diagnosis”. Especially, 
diagnostic delay was determined as diagnosis of PE more than 5-10 days after symptom 
onset in different studies. But delay in the diagnosis of PE was defined as shorter that was 
12-24 hours in 2 different studies. Actually  the time for delayed diagnosis of PE patients 
who have no diagnosis is an obscure area and therefore there is no known answer yet for 
answering the optimal time fort he diagnosis of PE.  
3. Diagnostic delays in PE and risk factors 
There is a limited data about the effect of risk factors on time to diagnosis of PE. PE is still a 
major cause of death in hospital patients, in medical service especially. Therefore medical 
risk factors are one of the important reasons leading to the diagnostic delay in PE. It is 
thought that previous hospitalization history may lead an idea of an inadequate prophylaxis 
or underestimation the diagnosis of PE. 
We retrospectively evaluated the records of 408 diagnosed with PE. The mean time to 
diagnosis was 4.39 ± 7.6 days (median, 2 days; range, 0-45 days) in the surgical group and 
8.0 ± 8.6 days (median, 4 days; range, 0-45 days) in the medical group. The percentage of 
cases diagnosed within the first week (87.5% of the surgical group, 66% of the medical 
group) was significantly higher in the surgical group patients with acute PE. In our study, 
the mean time to diagnosis in the medical group was approximately four times greater than 
that of the surgical group on univariate analysis. In multivariate analysis surgery, presence 
of cancer, and stroke were found to be related with early diagnosis in PE. We think that 
presence of medical disease is a risk factor for PE and can also mask PE symptoms, thus 
delaying diagnosis. Bulbul et al. also reported that patients with a trauma or surgical risk 
factor were diagnosed earlier (Bulbul,2009).  
In MASTER study, is an Italian, multicenter, observational study included 542 PE patients,  
was found by Ageno et al. the presence of transient risk factors (recent surgery, recent 
trauma, severe medical diseases, immobilization, pregnancy, puerperium, oral 
contraceptives, central venous catheters) for PE predicted earlier diagnosis of PE. As 
interesting, known thrombophilia, active cancer and previous PE or DVT was not predicted 
earlier diagnosis of PE in this study (Ageno, 2008).  
Castro et al. prospectively was evaluated 397 consecutive patients with acute PE objectively 
diagnosed in an Emergency Department. Eighteen percent of patients had a diagnostic 
delay with symptoms beginning more than 1 week prior to the diagnosis of PE. Similarly 
Castro et al found that active cancer, immobility and presence of previous VTE does not 
predict the early diagnosis of PE (Castro,2007). 
Berghaus et al. suggested that delay in diagnosis was significant greater in patients with 
recurrent than in patients with first PE (3.4 ± 2.3 vs. 2.2 ± 1.7 days) (Berghaus,2011). 
A recent study, Smith et al. studied 400 patients with acute PE who were diagnosed 
either within 12 h or after 12 h from ED arrival. They found that patients with delayed 
diagnosis were morbid obesity, whereas patients with early diagnosis more frequently 
had recent immobility (Smith,2011). Obesity that was found to be associated with the 
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delayed diagnosis of PE was composed of the 11.5% of the patients in this study.  
Immobility is important for obese patients so that delayed diagnosis is possibly related 
to the immobility. 
Actually, in patients with previous PE must be associated with early diagnosis of PE. Up to 
now, it is unknown whether patients with recurrent PE are diagnosed earlier than those 
with their first episode. Surprisingly, Barghaus et al. were found that patients with recurrent 
PE was not diagnosed earlier but even later than those with their first episode, although all 
enrolled patients reported common clinical signs of PE. They reported that delay in 
diagnosis after symptom onset was significantly greater in patients with recurrent than in 
patients with their first PE (3.4 ± 2.3 vs. 2.2 ± 1.7 days) (Barghaus,2011). 
In the light of the data above, effect of risk factors on the delayed diagnosis of PE seems to 
be contrversial. Especially in these mentioned studies, it has been seen that percentage of 
risk factors causing PE was various. 
For example immobility has been found as a risk factor of 42% of the PE patients in the 
study by Stein et al. whereas this percentage was 17% in the study by Castro et al. 
Threfore, it is diffucult to determine whether immobility causes early or late diagnosis of PE 
in this case. 
Immobility was found to be related to early diagnosis of PE in the univariate analysis of our 
study. We are on side of the opinion that presence of immobility is an obvious clue in the 
patients with PE suspicion for the early diagnosis. Similarly, surgery was present as a risk 
factior in 30% of our study population of PE in our study but this percentage was only 9% in 
study by Castro et al. 
Hospitalization of the most of the operated patients and development of PE after a short 
time of operation in these patients provides an easy way to diagnosis of PE. 
Immobility and the presence of cancer alone constitutes a low risk for PE according to Wells 
criteria. A frequent complication is the occurrence of venous thromboembolism , for which 
cancer is one of the most relevant risk factors..However diagnosis of PE was found as 
difficult in cancer patients in 2 different studies.It was seen that suspicion of PE diagnosis 
was present in 6(75%) of 8 patients in an autopsy study by Pineda et al..It is possible that 
symptoms and signs of these patients were associated with the cancer and diagnostic work-
up was not done. D-dimer positivity is an expected sign in cancer patients. Therefore 
presence of low risk with the D-dimer positivity needs CT pulmonary angiography in these 
patients.  Moreover recently appeared VTE (pulmonary embolism or deep vein thrombosis) 
occurred in 12-32% of cases with the diagnosis of cancer during follow-up period 
(Goldhaber 2004,. Kroger 2006).  
According to the recent data, asymptomatic DVT and PE was found in 8% and 3.3% of 
patients with the diagnosis of cancer during their screening workup by computerized 
tomography (Cronin 2006). These data showed that the diagnosis of PE was delayed in 
cancer patients. Therfore it is necessary to suspect the diagnosis of PE in cancer patients 
more than the others. 
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4. Diagnostic delays in PE and age 
The incidences of venous thromboembolism and PE are known to increase with age The 
patients with the diagnosis of PE were mostly above the 65 years old.  The annual incidence 
of PE is 1.3/1000 at age 65–69 years and 3.1/1000 at age 85–89 years of age [Kniffer, 1994]. 
With age is variable thrombotic/antithrombotic balance, fibrinogen levels increase and anti-
thrombin 3 levels decline [Hager,1989], while reduced lower limb musculature and 
immobility may encourage venous stasis. Although these physiological changes may 
predispose eldery persons to thromboembolism, there is also a rise in specific risk factors for 
thromboembolism with aging, such as congestive heart failure, stroke and hip fracture, 
among many comorbid condition (eg. cancer) 
An important factor leading to delay in PE diagnosis is age, but this contribution is also 
controversial. Several earlier studies found that the clinical presentation of older patients 
with acute PE may be atypical, potentially leading to a delay in diagnosis and initiation of 
treatment. Otherwise, in a recent study, Berghaus et al. found that delay in diagnosis had 
not was not significantly different in the younger and older age group(Berghaus, 2011). 
Contrary, in an autopsy studies was found that the post-mortem diagnosis of PE was 
significantly more frequent in older patients (Mangion, 1989) 
In this section, we will discuss impact of risk factors in delays according to literature.  
5. The impact of delay on outcome of embolism 
Diagnostic delay and its impact on outcome of the disease were studied in seven studies. In 
this section, we will discuss and review the impact of delays on mortality and recurrence 
rates of pulmonary embolism.  
5.1 Mortality 
Although early diagnosis of PE is thought to reduce mortality, sufficient data on the subject 
are still limited. Mortality of  PE has not been changed although the use of spiral BT increase 
rate of diagnosis in PE patients. 
In the 1950s, the results of large-scale autopsy studies showed that only 11 to 12% of patients 
with PE received correct diagnoses before death (Uhland,1964). Pineda and colleagues 
reported a 45 % rate of correct antemortem diagnosis in a study that was done from 1991 to 
1996 (Pineda,2001). Actually it has been seen that the mortality decrease according to the 
years. 
Two different study suggest that early or late diagnosis did not change PE mortality. 
There were no statistical differences between the 2 groups in terms of mortality in our study. 
Delay in diagnosis was not different between those who died and those who survived. The 
mean time to diagnosis in the 40 patients who died was 5.7 ± 6.7 days (median, 3 days; 
range, 0-30 days) and 7.1 ± 8.7 days (median, 3 days; range, 0-45 days) in those who 
survived. We found that earlier diagnosis had no impact on mortality (Ozsu,2011). 
Kline et al. found inhospital adverse outcomes (Death, circulatory shock, or endotracheal 
intubation for respiratory distress) of patients with delayed diagnosis were worse than those 
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of patients with PE diagnosed in the emergency department. Advers events were seen in 
30% of the patients who have delayed diagnosis compared to the advers events seen in 8.5% 
of the patients who have no delayed diagnosis of PE (Kline,2007). 
Approximately 30% of PE patients are died from PE without having any diagnosis. 
Patients presenting with PE who are immediately treated with anticoagulation have a lower 
rate of in-hospital death (1.5%) compared with those who are not treated (5–23%) 
(Douketis,1998). 
Smith et al. compared that patients receiving heparin either in the emergency department 
or after admission. They found patients who received heparin in the ED had lower in-
hospital (1.4% vs 6.7%) and 30-day (4.4% vs 15.3%) mortality rates as compared with 
patients given heparin after admission. Patients who achieved a therapeutic aPTT within 
24 h had lower in-hospital (1.5% vs 5.6%) and 30-day (5.6% vs 14.8% ) mortality rates as 
compared with patients who achieved a therapeutic aPTT after 24 h. In multiple logistic 
regression models, receiving heparin in the ED was remained predictive of reduced 
mortality, and ICU admission was remained predictive of increased mortality in the same 
study (Smith,2010).  
Studies concerning with the relationship between mortality and diagnostic delay of PE was 
done in patients already having the PE diagnosis.  These patients have PE diagnosis and 
survived anyway. However many patients are died from PE without having the 
antemortem PE diagnosis in postmortem studies. Delayed diagnosis of PE can be fatal 
according to these data. 
The main problem is to diagnose these PE patients who can be fatal early and to start their 
treatment. The patients were classified as high risk and non-high risk patients according to 
risk groups. This can affect the results. Because, hours or even minutes are important for 
these high risk patients. Moreover it is necessary to investigate the mortality of the high risk 
patients whose diagnosis was made within 6-12 hours 
Because there is no sufficient data about this subject. Thus effect of mortality on delayed 
diagnosis of PE may be understood more easily. Early diagnosis and treatment in PE is life-
saving. Guidelines recommend initiation of anticoagulation if clinical suspicion for PE is 
high, even prior to confirmatory testing. 
5.2 Re-embolism 
The most important long-term complication of PTE is re-embolism that is associated with 
considerable morbidity and mortality. Delay in diagnosis of PE may be associated with 
chronic thrombo-embolic pulmonary hypertension rather than re-embolism. However, there 
is well not documented this issue.  
Castro et al. did not detect an association between a delay in diagnosis and an PE recurrence 
during the ensuing 3 months of treatment. They found that recurrent VTE in 3 (4.2%) of 72 
patients with diagnostic delay and in 15 (4.6%) of 325 patients without diagnostic delay 
(Castro,2007) 
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6. Recommendations 
Late diagnosis also depends on patients delay in seeking medical awareness. In the North 
American study, 80%of the delay in diagnosis of DVT found before medical evaluation, 
whereas delays in the diagnosis of PE represented both delays in seeking medical attention 
and delays from medical assessment to proper objective testing [Elliott,2005]. It has been 
seen that many patients who had delayed diagnosis had admitted to a physcian before. 
Bulbul et al. showed that previous hospital or doctor visits were associated with an 
approximately 11 times longer diagnostic delay than the patients who did not visit a doctor 
or a hospital in univariate logistic regression analysis (Bulbul,2011). Data has been shown 
that there is no sufficient suspicion effort he diagnosis of PE.. 
Suspicion for PE is first step for the diagnosis of PE then it is necessary to perform rapid 
tests for the diagnosis. Bolus heparin should be done especially in high risk patients Clinical 
presentation is non-spesific for PTE and most important point in diagnosis is suspicion for 
PTE. Therefore more efforts are needed by experts effort he diagnosis of PE. 
In addition it has been known that there is no spesific marker for PE yet. Although 
negative predictive value of D-dimer is high, most of the patients admitted to the hospital 
have positive D-dimer level. Therefore advanced studies are needed for this issue. 
Another important point is that there is need for more spesific scoring systems of the PE 
diagnosis. 
Because history of previous VTE alone is classified as intermediate ris for the PE according 
to the Well’s criteria. However diagnosis is delayed in patients having VTE in studies. This 
is a obvious contraversion. Perhaps physicians do not use clinical scoring systems efficienly 
for the diagnosis of PE. 
Moreover it is known that both history given by patients and taken by physician is not 
sufficient for the diagnosis of PE. Also patients should be stratified for the diagnosis of PE. It 
was shown that level of patients’ education was related to the delayed diagnosis of PE 
(Bulbul, 2011). Because it was shown that even the patients having previous PE diagnosis 
had also delayed diagnosis of PE. 
Finally, public and professional education represents a critical step for the early diagnosis 
and treatment in this patients, especially. My opinion, earlier diagnoses of PE will reduce 
the morbidity and mortality associated with PE.  
 
Late presentation early presentation 
*Immobility Recent surgery/ trauma 
 
Idiopathic  Severe medical diseases 
*Elderly Pregnancy/ puerperium 
 
*Cancer  Oral contraceptives, 
Previous VTE central venous catheter 
*There are studies showed that these risk factors were related to the early presentation 
Table 2. Risk factors relation to early/late presentation. 
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Provide medical attention for diagnosis of PE
Public information/awareness
Diagnostic strategies in PE
Immobility
Previous VTE
Elderly
Cancer
Obesity
A doctor visity
Hospitalization
ASK Assessment of clinical probability
Low/intermediate or
Unlikely probability
Positive D-dimer
Multislice CT
PE-treatment No-PE
Multislice CT
High or
Likely probability
PE-treatment No-PE
If CT is negative in patients with high clinical probability, further investigation may 
be considered before withholding PE treatment and/or directly start to treatment
Adapted from reference 25
 
 
Table 3. Approach to diagnosis of PE. 
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